CSIMarket
 

Healthcare Sector

Biotechnology & Pharmaceuticals Industry  


Data by Company within Biotechnology & Pharmaceuticals Industry


  Marketcap Revenues (TTM) Net Income (TTM) Employees
Company (Millions) (Millions) (Millions) Number
Lenz Therapeutics Inc $ 86 - $ 0 -
Acorda Therapeutics Inc $ 1 $ 111 $ -16 327
Ocata Therapeutics, Inc. - - $ 0 -
Adaptimmune Therapeutics Plc $ 1,278 $ 25 $ -163 -
Fennec Pharmaceuticals Inc. - - $ 0 -
Adma Biologics Inc $ 2,603 $ 282 $ -4 256
Sophia Genetics Sa $ 298 $ 62 $ -79 -
Nkgen Biotech Inc $ 26 - $ -89 -
Adaptive Biotechnologies Corporation $ 476 $ 180 $ -196 645
Adverum Biotechnologies Inc $ 113 $ 2 $ -113 -
Aerie Pharmaceuticals Inc $ 729 $ 214 $ -37 259
Agenus Inc $ 5,926 $ 101 $ -283 -
Applied Genetic Technologies Corporation $ 26 $ 42 $ -70 -
Aura Biosciences Inc $ 271 - $ -71 -
Aim Immunotech Inc $ 19 $ 0 $ -29 -
Amarantus Bioscience Holdings, Inc. - - $ 0 -
Amarantus Bioscience Holdings, Inc. - - $ 0 -
Amgen Inc $ 170,528 $ 29,532 $ 3,763 24,200
Albany Molecular Research Inc $ 928 $ 681 $ -60 -
Aeolus Pharmaceuticals, Inc. $ 0 $ 1 $ -4 -
Century Therapeutics inc $ 167 $ 1 $ -133 -
Ariad Pharmaceuticals Inc - - $ 0 -
Arno Therapeutics, Inc - - $ 0 -
Asterias Biotherapeutics, Inc. $ 51 $ 3 $ -24 -
Peak Bio Inc $ 2 - $ -26 -
Atara Biotherapeutics Inc $ 882 $ 14 $ -290 -
Kubota Pharmaceutical Holdings Co Ltd - - $ 0 -
Anavex Life Sciences Corp $ 347 $ 3 $ -41 -
Biocardia Inc $ 71 $ 0 $ -10 -
Brainstorm Cell Therapeutics inc $ 25 - $ -16 -
Biocryst Pharmaceuticals Inc $ 1,292 $ 355 $ -209 192
Beesfree, Inc. - - $ 0 -
Bg Medicine, Inc. - - $ 0 -
Premier Biomedical Inc $ 0 $ 0 $ 0 -
Biogen Inc $ 33,061 $ 9,663 $ 1,167 9,610
Immucor Inc - - $ 0 -
Bluebird Bio Inc $ 111 $ 22 $ -91 -
Fusion Pharmaceuticals Inc $ 1,488 $ 2 $ 84 -
Bionovo Inc - - $ 0 -
Audentes Therapeutics Inc $ 240 - $ -166 -
Bohai Pharmaceuticals Group, Inc. $ 7 $ 165 $ 22 1,000
Zeo Scientifix Inc $ 0 $ 5 $ -5 -
Cadence Pharmaceuticals Inc - - $ 0 -
Cellular Biomedicine Group Inc $ 384 $ 0 $ -55 -
Axcella Health Inc $ 30 - $ -48 -
China Botanic Pharmaceutical - - $ 0 -
China Biologic Products Holdings Inc - $ 504 $ 163 4,572
Cellcyte Genetics Corp. - - $ 0 -
Cidara Therapeutics Inc $ 51 $ 72 $ -36 -
Vaxcyte Inc $ 8,464 - $ -316 -
Cullinan Oncology Inc $ 742 - $ -157 2
Compugen Ltd $ 162 $ 8 $ -34 -
Coherus Biosciences inc $ 205 $ 302 $ -59 650
Chelsea Therapeutics International, Ltd. - - $ 0 -
China Kangtai Cactus Bio-tech, Inc. - - $ 0 -
Forma Therapeutics Holdings Inc. - - $ -190 -
Prokidney Corp $ 142 - $ -222 -
Compass Biotechnologies Inc. - - $ 0 -
Core Lithium Corp. $ 251 - $ -4 -
Curis Inc $ 47 $ 10 $ -48 -
Crispr Therapeutics Ag $ 4,601 $ 170 $ -354 -
Gene Biotherapeutics Inc $ 0 - $ -1 -
Champions Oncology Inc $ 67 $ 49 $ -10 -
Oyster Point Pharma Inc $ 300 $ 20 $ -235 -
Cel sci Corporation $ 64 - $ -30 -
Ikena Oncology Inc $ 73 $ 14 $ -63 -
Diadexus, Inc. - - $ 0 -
Dimension Therapeutics, Inc. $ 149 $ 17 $ -56 -
Dendreon Corp - - $ 0 -
Estrella Immunopharma Inc $ 33 - $ -4 -
Kymera Therapeutics Inc $ 1,624 $ 67 $ -103 -
Noho, Inc. - - $ 0 -
Ds Healthcare Group, Inc. $ 0 $ 12 $ -6 105
Rubius Therapeutics Inc $ 5 - $ -180 -
Editas Medicine Inc $ 416 $ 69 $ -166 -
Eiger Biopharmaceuticals Inc $ 3 $ 16 $ -75 -
Abcam Plc $ 5,511 - $ 0 -
Apogee Therapeutics inc $ 1,957 - $ 0 -
Enumeral Biomedical Holdings, Inc. $ 0 $ 2 $ -13 -
Enzon Pharmaceuticals inc $ 13 $ 2 $ 1 -
Enzymotec Ltd. - - $ 0 124
Entia Biosciences, Inc. $ 0 $ 0 $ -1 -
Scinai Immunotherapeutics Ltd $ 5,250 - $ 7 -
Eastgate Biotech Corp - $ 0 $ -3 -
Revolution Medicines Inc $ 4,205 $ 30 $ -331 -
Exelixis Inc $ 6,819 $ 1,847 $ 464 566
Fate Therapeutics Inc $ 379 $ 106 $ -173 208
Global Future City Holding Inc. $ 3 $ 3 $ -5 -
Agentix Corp - - $ -1 2
Elutia Inc $ 93 $ 28 $ -48 -
Fennec Pharmaceuticals Inc - - $ 0 -
Codiak Biosciences Inc $ 1 $ 34 $ -17 -
Gentium S.p.a. - - $ 0 -
Synageva Biopharma Corp - - $ 0 -
Gilead Sciences Inc $ 88,200 $ 27,450 $ 458 14,400
Genocea Biosciences Inc $ 0 $ 21 $ -37 -
Aevi Genomic Medicine, Inc. $ 11 - $ -18 -
Genenta Science S p a $ 61 - $ -13 -
Intensity Therapeutics Inc $ 70 - $ 0 -
Ginkgo Bioworks Holdings Inc $ 734 $ 255 $ -847 -
Calidi Biotherapeutics Inc $ 7 - $ -34 -
Green Planet Bioengineering Co Ltd $ 12 - $ 0 -
Genethera Inc $ 0 - $ -1 -
Halozyme Therapeutics Inc $ 6,710 $ 863 $ 319 3,011
Zura Bio Limited $ 159 - $ -17 -
Hyperion Therapeutics Inc - - $ 0 -
Intellect Neurosciences, Inc. $ 0 - $ -15 -
Epicure Charcoal, Inc. $ 0 - $ 0 -
Chromocell Therapeutics Corporation $ 7 - $ 0 -
Outlook Therapeutics Inc $ 106 - $ -159 -
Jounce Therapeutics inc $ 97 $ 148 $ 0 125
Juno Therapeutics, Inc. $ 9,815 $ 112 $ -437 -
Cadus Corp $ 42 - $ -3 -
Kite Pharma, Inc. $ 10,187 $ 32 $ -359 -
Lescarden Inc - - $ 0 -
Turnstone Biologics Corp $ 48 - $ 0 -
Hillevax Inc $ 524 - $ -108 -
Atyr Pharma Inc $ 110 $ 10 $ -43 -
La Jolla Pharmaceutical Company $ 200 $ 46 $ 4 -
Logicbio Therapeutics Inc $ 185 $ 11 $ -27 -
Mabvax Therapeutics Holdings, Inc. $ 2 - $ -20 -
Multicell Technologies, Inc. $ 0 $ 0 $ -1 -
Manhattan Pharmaceuticals Inc - - $ 0 -
Sorrento Therapeutics Inc $ 18 - $ 0 -
Mj Pharmaceuticals Inc. - - $ 0 -
Lexeo Therapeutics Inc $ 28 - $ 0 -
Sqz Biotechnologies Company $ 1 - $ 0 -
Momenta Pharmaceuticals inc $ 6,187 $ 30 $ -228 -
Ambrx Biopharma Inc $ 1,743 $ 9 $ -134 -
Mymetics Corporation $ 0 $ 1 $ -14 -
Myrexis, Inc. - - $ 0 -
Neurocrine Biosciences Inc $ 13,843 $ 1,982 $ 370 1,000
Northsight Capital, Inc. - $ 0 $ -2 -
Nexus Biopharma Inc - - $ 0 -
10x Capital Venture Acquisition Corp Iii - - $ -1 -
Nanostring Technologies Inc $ 5 $ 162 $ -166 721
Nbty Inc - - $ 0 -
Nutrastar International Inc. - - $ 0 -
Novavax inc $ 1,962 $ 997 $ -399 370
N-viro International Corporation - - $ 0 -
Cardiff Oncology inc $ 105 $ 5 $ -42 -
Spark Therapeutics Inc $ 4,257 $ 58 $ -80 -
Organovo Holdings Inc $ 7 $ 0 $ -19 -
Old Ayala Inc $ 8 $ 1 $ -38 -
Osiris Therapeutics, Inc. $ 656 $ 113 $ 5 -
Oncovista Innovative Therapies, Inc - - $ 0 -
Point Of Care Nano technology Inc $ 0 - $ 0 -
Quint Media Inc. - - $ 0 -
Protalix Biotherapeutics inc $ 94 $ 60 $ 7 -
Pharmacyte Biotech Inc - - $ -3 -
Tenaya Therapeutics Inc $ 228 - $ -128 -
Candel Therapeutics Inc $ 178 $ 0 $ -32 -
Achilles Therapeutics Plc $ 33 - $ -71 -
Autolus Therapeutics Plc $ 826 $ 0 $ -149 -
Mosaic Immunoengineering Inc $ 0 - $ -1 -
Qiagen N v $ 9,693 $ 1,901 $ 341 5,700
Quint Media Inc. - - $ 0 -
Rich Pharmaceuticals, Inc. $ 0 - $ 0 -
Regenocell Therapeutics, Inc. - - $ 0 -
Receptos, Inc. - - $ 0 -
Restorgenex Corp - - $ 0 -
Regado Biosciences Inc - - $ 0 -
Repligen Corp $ 7,022 $ 670 $ 116 1,170
Regenxbio Inc $ 561 $ 99 $ -261 300
Invivyd Inc $ 139 - $ -170 -
Aytu Bioscience, Inc. - - $ 0 -
Ruthigen, Inc. - - $ 0 -
Immunovant Inc $ 3,776 - $ -259 -
Radient Pharmaceuticals Corp - - $ 0 -
Neumora Therapeutics Inc $ 444 - $ 0 -
Dyadic International Inc $ 46 $ 2 $ -8 84
Seagen Inc $ 43,034 $ 2,300 $ -750 2,700
Sangamo Therapeutics Inc $ 85 $ 19 $ -328 411
Shengtai Pharmaceutical, Inc. - - $ 0 -
Senti Biosciences Inc $ 12 $ 4 $ -64 -
Spotlight Innovation Inc. $ 0 $ 0 $ -5 2
Savient Pharmaceuticals Inc - - $ 0 -
Tobira Therapeutics, Inc. - - $ 0 -
Tracon Pharmaceuticals Inc $ 45 $ 11 $ -11 -
Bio techne Corp $ 11,923 $ 1,143 $ 224 3,000
Telik Inc - - $ 0 -
Mabvax Therapeutics Holdings, Inc. - - $ 0 -
Tg Therapeutics, Inc. - - $ 0 -
Instil Bio Inc $ 65 $ 1 $ -167 -
Alvotech - - $ 0 -
Targeted Medical Pharma, Inc. - - $ 0 -
Targacept Inc - - $ 0 -
Trius Therapeutics Inc - - $ 0 -
Titan Pharmaceuticals Inc $ 6 $ 2 $ -5 -
Taxus Pharmaceuticals Holdings, Inc. $ 2,201 - $ 0 -
Uluru Inc. $ 35 $ 1 $ -2 -
United Bancshares Inc - - $ 0 -
Vericel Corporation $ 2,224 $ 208 $ 0 -
Viropharma Inc - - $ 0 -
Ventrus Biosciences Inc - - $ 0 -
Voyager Therapeutics Inc $ 460 $ 119 $ -3 -
Windtree Therapeutics Inc $ 2 $ 1 $ -6 -
Acceleron Pharma inc $ 10,892 $ 113 $ -255 450
Xstelos Holdings, Inc. - - $ 0 -
Xtant Medical Holdings Inc $ 41 $ 90 $ 1 -
Zivo Bioscience Inc $ 22 $ 0 $ -7 2
Cabaletta Bio Inc $ 371 - $ -62 -
Iovance Biotherapeutics inc $ 2,172 $ 2 $ -450 -
Biomx Inc - - $ 38 -
Vir Biotechnology Inc $ 1,239 $ 80 $ -539 -
Qrons Inc $ 2 - $ -1 -
Krystal Biotech Inc $ 5,221 - $ 57 -
Springworks Therapeutics Inc - - $ -348 -
Allena Pharmaceuticals Inc. $ 8 - $ -43 -
Eloxx Pharmaceuticals Inc $ 2 - $ -32 -
Nightstar Therapeutics Plc $ 840 - $ -53 -
Avrobio Inc $ 62 - $ -4 -
Solid Biosciences Inc $ 133 $ 15 $ -91 -
Sab Biotherapeutics Inc $ 155 $ 4 $ -27 -
Denali Therapeutics Inc $ 3,423 $ 341 $ 8 340
Armo Biosciences, Inc. - - $ 0 -
Surface Oncology Inc $ 65 $ 31 $ -93 -
Luckwel Pharmaceuticals Inc. - - $ 0 -
Aptose Biosciences Inc $ 5 - $ -49 -
Meiragtx Holdings Plc $ 273 $ 11 $ -74 -
Gritstone Bio Inc $ 87 $ 10 $ -71 -
Mesoblast Ltd $ 5,011 $ 8 $ -82 -
Jasper Therapeutics Inc $ 2,469 - $ -61 -
Genetic Technologies Ltd - $ 0 $ -6 -
Sutro Biopharma Inc $ 186 $ 49 $ -172 -
Kodiak Sciences Inc $ 143 - $ -271 -
Allogene Therapeutics Inc $ 441 $ 0 $ -294 -
Twist Bioscience Corporation $ 2,846 $ 277 $ -192 750
X4 Pharmaceuticals Inc $ 202 - $ -134 -
Polarityte Inc $ 1 $ 3 $ -8 -
Cellectis S a $ 86 $ 57 $ -125 -
Replicel Life Sciences Inc - - $ -1 -
Orchard Therapeutics Plc $ 3,814 $ 22 $ -73 -
Inmune Bio Inc $ 136 $ 0 $ -27 -
Erytech Pharma S a $ 18 - $ -60 -
Scholar Rock Holding Corp $ 806 $ 47 $ -183 -
Alector Inc $ 385 $ 96 $ -141 155
Dbv Technologies S a $ 92 $ 15 $ -80 -
Kaleido Biosciences Inc $ 0 $ 1 $ -87 -
Tevogen Bio Holdings Inc $ 4 - $ 0 -
Vaxart Inc $ 126 $ 9 $ -82 -
Inhibikase Therapeutics Inc $ 7 $ 0 $ -19 -
Tcr2 Therapeutics Inc $ 62 - $ -163 -
Precision Biosciences Inc $ 1,092 $ 52 $ -74 -
Prevail Therapeutics Inc $ 774 - $ -24 -
Protara Therapeutics Inc $ 25 - $ -69 -
Black Diamond Therapeutics Inc $ 253 - $ -80 -
Biontech Se $ 21,037 $ 4,277 $ 1,042 1,700
Creative Medical Technology Holdings Inc $ 5 $ 0 $ -5 -
Beam Therapeutics Inc $ 1,962 $ 82 $ -314 -
Ocugen Inc $ 324 - $ -59 -
Relay Therapeutics Inc $ 843 $ 26 $ -327 -
Genfit S a $ 196 $ 43 $ -32 194
Lineage Cell Therapeutics Inc $ 161 $ 9 $ -23 -
Tc Biopharm holdings Plc $ 5 $ 4 $ -1 -
Poseida Therapeutics Inc $ 253 $ 52 $ -132 -
Iteos Therapeutics Inc $ 533 $ 128 $ -62 97
Checkmate Pharmaceuticals Inc $ 227 - $ -63 -
Replimune Group Inc $ 583 - $ -216 -
Passage Bio Inc $ 51 - $ -84 -
Allovir Inc $ 89 - $ -169 -
Kiromic Biopharma Inc $ 3 - $ -22 -
Immunitybio inc $ 4,939 $ 0 $ -601 -
Taysha Gene Therapies Inc $ 334 $ 14 $ -215 -
Inhibrx Inc $ 844 $ 2 $ -271 -
C4 Therapeutics Inc $ 322 $ 20 $ -126 -
Athira Pharma Inc $ 90 - $ -121 -
Omega Therapeutics Inc $ 133 $ 3 $ -108 -
Aligos Therapeutics Inc $ 19 $ 16 $ -82 -
Tarsus Pharmaceuticals Inc $ 933 $ 17 $ -148 -
Palisade Bio Inc $ 34 - $ -13 -
Cyclo Therapeutics Inc $ 34 $ 1 $ -19 -
Compass Therapeutics Inc $ 152 - $ -45 -
4d Molecular Therapeutics Inc $ 982 $ 22 $ -96 -
Evaxion Biotech A $ 73 $ 0 $ -22 -
Freeline Therapeutics Holdings Plc $ 384 - $ -140 -
Greenlight Biosciences Holdings Pbc $ 45 $ 10 $ -157 -
Innate Pharma Sa $ 170 $ 69 $ -8 -
Vor Biopharma Inc $ 84 - $ -116 -
Recursion Pharmaceuticals Inc $ 2,204 $ 46 $ -354 -
Finch Therapeutics Group Inc $ 2 $ 1 $ -100 -
Bioatla Inc $ 75 - $ -124 -
Moderna Inc $ 52,334 $ 5,153 $ -5,968 2,700
Monte Rosa Therapeutics Inc $ 190 - $ -133 -
Spk Acquisition Corp - - $ -1 -
Miromatrix Medical inc $ 93 $ 1 $ -32 -
Elevation Oncology inc $ 116 - $ -39 -
Armata Pharmaceuticals Inc $ 106 $ 5 $ -80 -
Acumen Pharmaceuticals Inc $ 134 - $ -56 -
Atlantic Coastal Acquisition Corp Ii $ 210 - $ 3 -
Tscan Therapeutics Inc $ 634 $ 17 $ -88 -
Caribou Biosciences Inc $ 167 $ 33 $ -115 -
Avalon Globocare Corp $ 5 $ 1 $ -9 -
In8bio Inc $ 28 - $ -30 -
Icosavax Inc $ 766 $ 1 $ -97 -
Opthea Limited $ 854 $ 0 $ -143 -
Humacyte Inc $ 552 - $ -106 -
Surrozen Inc $ 311 - $ -35 -
Renovacor Inc $ 56 - $ -4 -
Cognition Therapeutics inc $ 62 - $ -29 -
Clarus Therapeutics Holdings Inc. $ 2 $ 8 $ -23 -
Mink Therapeutics Inc $ 31 - $ -25 -
Apeiron Capital Investment Corp $ 180 - $ 7 -
Cannabis Global Inc. $ 0 $ 4 $ -4 -
Phoenix Biotech Acquisition Corp $ 65 - $ -3 -
Entera Bio Ltd $ 76 - $ 9 -
Tourmaline Bio Inc $ 354 - $ -33 -
Molecular Partners Ag $ 236 $ 7 $ -62 -
Sana Biotechnology Inc $ 1,111 - $ -280 -
Exscientia Plc $ 261 - $ 0 -
Valneva Se $ 1,086 $ 172 $ -114 550
Gamida Cell Ltd $ 5 - $ 79 -
Vectivbio Holding Ag $ 745 $ 27 $ -94 -
Immunocore Holdings Plc $ 1,787 - $ 0 -
Arcellx Inc $ 2,716 - $ -130 -
Vigil Neuroscience Inc $ 151 - $ -79 -
Pluri Inc $ 26 $ 0 $ -22 -
Prime Medicine Inc $ 652 - $ 0 -
Fresh Tracks Therapeutics Inc $ 5 $ 10 $ -6 -
Coeptis Therapeutics Holdings Inc $ 11 - $ -17 -
Scilex Holding Company $ 250 $ 71 $ -117 -
Ladrx Corporation $ 1 - $ 2 -
Cardiol Therapeutics inc $ 129 - $ -22 -
Aceragen Inc $ 3 - $ -41 -
Redwoods Acquisition Corp $ 42 - $ 5 -
Argenx se $ 25,188 $ 2,495 $ -295 -
Cargo Therapeutics Inc $ 12 - $ 0 -
Cortexyme Inc - - $ -90 -
Biotechnology & Pharmaceuticals Industry $ 666,200 $ 97,875 $ -19,694 82,650
Earnings Earnings Earnings
Earnings Outlook increase
Looking into earnings estimates within the Biotechnology & Pharmaceuticals Industry in the current quarter, 33.33 % of companies, who provide earning guidance within Biotechnology & Pharmaceuticals Industry have increased their earnings outlook for the current fiscal year. But this falls short, as more corporations cut their earnings estimates.
Earnings Guidance unchanged
In the same quarter, none of those companies, who issued earnings outlook, has reiterated its earnings estimates within the Biotechnology & Pharmaceuticals Industry.
Earnings Estimates decrease
Pessimism dominates within Biotechnology & Pharmaceuticals Industry, as most of the businesses cut their earnings guidance, staggering 66.67 % have revised down earnings outlook. Overall earnings expectations for the Biotechnology & Pharmaceuticals Industry were cut by %, to the annual earnings expectation of %.


Expected Eps Growth Eps Expectation Revision
n   %     Industry Expected EPS Growth
Total Ranking # Within Sector #
n   %   Industry Earnings Outlook Revision
Total Ranking # Within Sector #
Revenue Revenue Revenue
Sales Forecast increase
In the current quarter 66.67 % of companies, who have issued revenue expectation within Biotechnology & Pharmaceuticals Industry, have expressed their optimism, by increasing revenue outlook for the current fiscal year.
Sales Expectations unchanged
Among companies who provide sales guidance within Biotechnology & Pharmaceuticals Industry 33.33 %, have reiterated own sales estimates for the current fiscal year.
Sales Outlook decrease
In Biotechnology & Pharmaceuticals Industry, there were no sales guidance decreases
Expected Revenue Growth Revenue Expectation Revision
  %     Industry Expected Revenue Growth
Total Ranking # Within Sector #
  %   Industry Revenue Outlook Revision
Total Ranking # Within Sector #





Cardiovascular Segment
Revenues Income
- - - -
Y/Y Q/Q Y/Y Q/Q

Neuroscience Segment
Revenues Income
- - - -
Y/Y Q/Q Y/Y Q/Q

Anti-Infective Segment
Revenues Income
- - - -
Y/Y Q/Q Y/Y Q/Q

Respiratory Segment
Revenues Income
- - - -
Y/Y Q/Q Y/Y Q/Q

Arthritis & Pain Segment
Revenues Income
- - - -
Y/Y Q/Q Y/Y Q/Q

Urology Segment
Revenues Income
- - - -
Y/Y Q/Q Y/Y Q/Q

Oncology Segment
Revenues Income
- - - -
Y/Y Q/Q Y/Y Q/Q

Endocrine Segment
Revenues Income
- - - -
Y/Y Q/Q Y/Y Q/Q




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com